ARCHIVES

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

This article is from The Cancer Letter archive.

Vol. 21 No. 37 | September 29, 1995

Download PDF Visit The Full Archive

Related Articles

DCCP Board Okays New Projects In Chemoprevention, Other Programs Totaling $5 Million In First Year

December 14, 1979

Prostate Cancer Patient Groups Consider formation Of Coalition Using the “NBCC Model”

August 16, 1996

NCI Programs: Advisors Approve Plans For New Grants In Imaging Research

July 10, 1998

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Research Opportunities In Pancreas Cancer Described; Top Priority Set

December 21, 1973

NIH Considering Longer grant Award Periods; CCIRC’s New Bosses Crack Dow On Conferences

November 10, 1978